Tumorigenicity of five dihydrodiols of benz(a)anthracene on mouse skin: exceptional activity of benz(a)anthracene 3,4-dihydrodiol.

Benz[a]anthracene and the five metabolically possible vicinal trans dihydrodiols of benz[a]anthracene were tested for ability to initiate skin tumors in CD-1 female mice. A single topical application of 0.4-2.0 mumol of hydrocarbon was followed 18 days later by twice weekly applications of the skin promoter 12-O-tetradecanoylphorbol-13-acetate. Comparisons of latency period, percent of mice with tumors, and number of papillomas observed per mouse indicated that benz[a]anthracene 1,2-, 5,6-, 8,9-, and 10, 11-dihydrodiols were all less active tumor initiators than was benz[a]anthracene. The high tumorigenicity of benz[a]anthracene 3,4-dihydrodiol, presumably the result of metabolism to either or both of the diastereomeric benz[a]anthracene 3,4-diol-1,2-epoxides, supports the bay region theory of polycyclic hydrocarbon carcinogenicity and provides the first example of a proximate carcinogenic metabolite that is much more active than the parent hydrocarbon on mouse skin.

[1]  D. Jerina,et al.  BENZO(A)PYRENE 7,8-DIHYDRODIOL IS MORE CARCINOGENIC THAN BENZO(A)PYRENE IN NEWBORN MICE , 1977 .

[2]  M. Schaefer-Ridder,et al.  Mutagenicity and cytotoxicity of benz[alpha]anthracene diol epoxides and tetrahydro-epoxides: exceptional activity of the bay region 1,2-epoxides. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Schaefer-Ridder,et al.  Synthesis and properties of the vicinal trans dihydrodiols of anthracene, phenanthrene, and benzo[a]anthracene , 1977 .

[4]  D. Jerina,et al.  (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo (a)pyrene: a potent skin carcinogen when applied topically to mice. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Y. Lu,et al.  Mutagenicity of metabolically activated benzo[a]anthracene 3,4-dihydrodiol: evidence for bay region activation of carcinogenic polycyclic hydrocarbons. , 1976, Biochemical and biophysical research communications.

[6]  R. Newbold,et al.  Exceptional mutagenicity of a benzo[a]pyrene diol epoxide in cultured mammalian cells , 1976, Nature.

[7]  B. Ames,et al.  Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals: discussion. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[8]  L. Sachs,et al.  Identification of mutagenic metabolites of benzo(a)pyrene in mammalian cells. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Jerina,et al.  Mutagenicityand Cytotoxicityof Benzo(a)pyreneBenzo-Ring Epoxides , 1976 .

[10]  D. Jerina,et al.  Carcinogenicity of benzo[a]pyrene 4,5-, 7,8-, and 9,10-oxides on mouse skin. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[11]  B. Ames,et al.  Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Bartsch,et al.  Mutagenicity of non-K-region diols and diol-epoxides of benz(a)anthracene and benzo(a)pyrene in S. typhimurium TA 100. , 1975, Biochemical and biophysical research communications.

[13]  E. Hecker,et al.  Autoxidation of phorbol esters under normal storage conditions. , 1975, Cancer research.

[14]  J. Trosko,et al.  The role of DNA repair and somatic mutation in carcinogenesis. , 1975, Advances in cancer research.

[15]  A. Hewer,et al.  Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide , 1974, Nature.

[16]  P. Sims,et al.  8,9‐Dihydro‐8,9‐dihydroxybenz(a)anthracene 10,11‐oxide: A new type of polycyclic aromatic hydrocarbon metabolite , 1974, FEBS letters.

[17]  A. Hewer,et al.  Polycyclic hydrocarbon epoxides: The involvement of 8,9‐dihydro‐8,9‐dihydroxybenz (a) anthracene 10,11‐oxide in reactions with the DNA of benz (a) anthracene‐treated hamster embryo cells , 1974, FEBS letters.

[18]  D. Jerina,et al.  Arene oxides: a new aspect of drug metabolism. , 1974, Science.

[19]  E. Miller,et al.  CHAPTER X – Biochemical Mechanisms of Chemical Carcinogenesis , 1974 .

[20]  P. Grover,et al.  Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis. , 1974, Advances in cancer research.

[21]  F. Oesch,et al.  Induction, activation and inhibition of epoxide hydrase: an anomalous prevention of chlorobenzene-induced hepatotoxicity by an inhibitor of epoxide hydrase. , 1973, Chemico-biological interactions.

[22]  E. Bresnick,et al.  Induction of aryl hydrocarbon hydroxylase in mouse tissues from a high and low cancer strain and their F 1 hybrids. , 1973, Journal of the National Cancer Institute.

[23]  J A Miller,et al.  Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture. , 1970, Cancer research.

[24]  E. Boyland,et al.  Metabolism of polycyclic compounds. 26. The hydroxylation of some aromatic hydrocarbons by the ascorbic acid model hydroxylating system and by rat-liver microsomes. , 1964, The Biochemical journal.

[25]  E. Boyland,et al.  Metabolism of polycyclic compounds. 24. The metabolism of benz[α]anthracene , 1964 .

[26]  E. Boyland,et al.  Metabolism of polycyclic compounds: Production of dihydroxydihydroanthracene from anthracene. , 1936, The Biochemical journal.